ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,978 | +29640.4% | 143,299 | +1418.0% | 0.04% | – |
| Q2 2023 | $47 | 0.0% | 9,440 | 0.0% | 0.00% | – |
| Q1 2023 | $47 | -20.3% | 9,440 | 0.0% | 0.00% | – |
| Q4 2022 | $59 | -99.9% | 9,440 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $102,000 | -5.6% | 9,440 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $108,000 | +25.6% | 9,440 | 0.0% | 0.00% | – |
| Q1 2022 | $86,000 | -39.0% | 9,440 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $141,000 | -42.0% | 9,440 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $243,000 | -1.2% | 9,440 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $246,000 | -26.1% | 9,440 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $333,000 | +39.9% | 9,440 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $238,000 | -33.1% | 9,440 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $356,000 | -11.9% | 9,440 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $404,000 | – | 9,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |